Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy-Reference-Cited by-同舟云学术

Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy

Published:2018-05-21 Issue:6 Volume:24 Page:758-769
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Wang Lu,Zhao Zibo,Ozark Patrick A.,Fantini Damiano,Marshall Stacy A.,Rendleman Emily J.,Cozzolino Kira A.,Louis Nundia,He Xingyao,Morgan Marc A.,Takahashi Yoh-hei,Collings Clayton K.,Smith Edwin R.,Ntziachristos Panagiotis,Savas Jeffrey N.,Zou Lihua,Hashizume Rintaro,Meeks Joshua J.,Shilatifard Ali^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/s41591-018-0034-6.pdf

Reference59 articles.

1. Morgan, M. A. & Shilatifard, A. Chromatin signatures of cancer. Genes Dev. 29, 238–249 (2015).

2. Plass, C. et al. Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer. Nat. Rev. Genet. 14, 765–780 (2013).

3. Hamamoto, R. et al. SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells. Nat. Cell Biol. 6, 731–740 (2004).

4. Kotake, Y. et al. pRB family proteins are required for H3K27 trimethylation and Polycomb repression complexes binding to and silencing p16 INK4α tumor suppressor gene. Genes Dev. 21, 49–54 (2007).

5. Mazur, P. K. et al. SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer. Nature 510, 283–287 (2014).

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The modification role and tumor association with a methyltransferase: KMT2C;Frontiers in Immunology;2024-08-06

2. KDM6A–SND1 interaction maintains genomic stability by protecting the nascent DNA and contributes to cancer chemoresistance;Nucleic Acids Research;2024-06-08

3. ASXLs binding to the PHD2/3 fingers of MLL4 provides a mechanism for the recruitment of BAP1 to active enhancers;Nature Communications;2024-06-07

4. Deciphering the interplay of histone post-translational modifications in cancer: Co-targeting histone modulators for precision therapy;Life Sciences;2024-06

5. KMT2C and KMT2D aberrations in breast cancer;Trends in Cancer;2024-06